Kindred Biosciences, Inc. (NASDAQ:KIN) Expected to Post Quarterly Sales of $960000.00

Retrieved on: 2021-01-21 06:22:30

Tags for this article:

Click the tags to see associated articles and topics

Kindred Biosciences, Inc. (NASDAQ:KIN) Expected to Post Quarterly Sales of $960000.00. View article details on hiswai:

Excerpt

Acadian Asset Management LLC now owns 284,689 shares of the biopharmaceutical company's stock valued at $1,221,000 after purchasing an ...

Article found on: www.marketbeat.com